Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F22%3A00125081" target="_blank" >RIV/00216224:14310/22:00125081 - isvavai.cz</a>
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/B9780128237335000167" target="_blank" >https://www.sciencedirect.com/science/article/pii/B9780128237335000167</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/B978-0-12-823733-5.00016-7" target="_blank" >10.1016/B978-0-12-823733-5.00016-7</a>
Alternative languages
Result language
angličtina
Original language name
Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis
Original language description
More and more people suffer from a variety of chronic inflammatory diseases, which are mainly caused by stress and a deteriorating environment. Chronic inflammatory bowel diseases are one of the most common such diseases. Their treatment is problematic and lengthy, and in fact, patients are never really cured. In addition, these diseases are associated with a number of other intestinal problems. The intestinal microbiome is a great help in the fight against these chronic diseases. This chapter summarizes current literature data on the role of microbiota in the development of human colon diseases. Special attention is paid to the involvement of sulfate- reducing bacteria in the development of ulcerative colitis. They are characterized by methods of molecular hydrogen metabolism by sulfate-reducing bacteria in the intestine. The influence and mechanism of action of the main product of metabolism of these microorganisms—hydrogen sulfide—on cells is described. The properties of antimicrobial drugs used in intestinal diseases are presented, and the importance of probiotics for the prevention and treatment of intestinal diseases is described.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
10606 - Microbiology
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Probiotics in the Prevention and Management of Human Diseases : A Scientific Perspective
ISBN
9780128237335
Number of pages of the result
34
Pages from-to
59-92
Number of pages of the book
509
Publisher name
Elsevier
Place of publication
Cambridge
UT code for WoS chapter
—